-+ 0.00%
-+ 0.00%
-+ 0.00%

JOURNEY MEDICAL CORPORATION LAUNCHES EMROSI™ (40 MG MINOCYCLINE HYDROCHLORIDE MODIFIED-RELEASE CAPSULES, 10 MG IMMEDIATE RELEASE AND 30 MG EXTENDED RELEASE) FOR THE TREATMENT OF ROSACEA

Reuters·03/24/2025 12:30:01

Please log in to view news